Publication | Closed Access

A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression

PsychiatryMood SymptomMedicinePsychotropic MedicationPsychopharmacologyDepressionNeuropharmacologyPlacebo-controlled TrialOnce-daily VenlafaxinePharmacotherapyMood DisordersSocial SciencesMental HealthPharmacologyPsychopathologySide Effect